Victory Capital Management Inc. reduced its position in Express Scripts Holding Co (NASDAQ:ESRX) by 6.7% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 245,341 shares of the company’s stock after selling 17,726 shares during the period. Victory Capital Management Inc.’s holdings in Express Scripts were worth $18,943,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in ESRX. Hendershot Investments Inc. grew its stake in shares of Express Scripts by 2.7% during the 2nd quarter. Hendershot Investments Inc. now owns 89,125 shares of the company’s stock valued at $6,881,000 after buying an additional 2,380 shares during the period. Stock Yards Bank & Trust Co. purchased a new stake in shares of Express Scripts during the 2nd quarter valued at $1,084,000. Reinhart Partners Inc. purchased a new stake in shares of Express Scripts during the 2nd quarter valued at $20,509,000. Systematic Financial Management LP purchased a new stake in shares of Express Scripts during the 1st quarter valued at $1,129,000. Finally, Rockefeller Capital Management L.P. purchased a new stake in shares of Express Scripts during the 1st quarter valued at $1,529,000. 84.52% of the stock is owned by hedge funds and other institutional investors.

Shares of Express Scripts stock opened at $87.39 on Friday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.71 and a quick ratio of 0.59. Express Scripts Holding Co has a twelve month low of $55.80 and a twelve month high of $87.69. The firm has a market cap of $47.02 billion, a P/E ratio of 12.31, a price-to-earnings-growth ratio of 1.05 and a beta of 0.95.

Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings results on Wednesday, August 1st. The company reported $2.22 earnings per share for the quarter, topping analysts’ consensus estimates of $2.20 by $0.02. Express Scripts had a net margin of 4.65% and a return on equity of 25.49%. The firm had revenue of $25.64 billion during the quarter, compared to analysts’ expectations of $25.43 billion. During the same period in the prior year, the company earned $1.73 EPS. The firm’s revenue was up 1.2% on a year-over-year basis. sell-side analysts expect that Express Scripts Holding Co will post 9.07 earnings per share for the current year.

In related news, insider Christine Houston sold 12,898 shares of the company’s stock in a transaction on Friday, August 10th. The shares were sold at an average price of $85.00, for a total transaction of $1,096,330.00. Following the completion of the sale, the insider now directly owns 110,908 shares of the company’s stock, valued at approximately $9,427,180. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.79% of the stock is currently owned by corporate insiders.

ESRX has been the subject of several research reports. ValuEngine raised shares of Express Scripts from a “hold” rating to a “buy” rating in a research note on Thursday, April 26th. BidaskClub raised shares of Express Scripts from a “hold” rating to a “buy” rating in a research note on Thursday, April 26th. Zacks Investment Research cut shares of Express Scripts from a “hold” rating to a “sell” rating in a research note on Tuesday, May 1st. Leerink Swann lowered their price objective on shares of Express Scripts from $90.00 to $80.00 and set a “market perform” rating for the company in a research note on Thursday, May 3rd. Finally, Barclays lowered their price objective on shares of Express Scripts from $84.00 to $83.00 and set an “equal weight” rating for the company in a research note on Thursday, May 3rd. Three analysts have rated the stock with a sell rating, thirteen have issued a hold rating and four have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $83.58.

About Express Scripts

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Recommended Story: Earnings Per Share (EPS) Explained

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.